HSBC's double-downgrade is a meaningful bearish signal from a mid-accuracy firm, but the consensus remains bullish and institutional buying is strong. Traders should treat this as a caution flag rather than a full reversal — the elevated short interest suggests the bearish view is already priced in, and the $24 low target provides a floor.
Price Chart
Executive Summary
HSBC double-downgraded Pfizer (PFE) from Buy to Hold on July 6, 2026, slashing the price target to $28 from $32, implying a 15.1% upside from the current $24.32. The firm has a 55% accuracy rate on 263 calls with an average return of 5.5%, placing it in the middle of the pack among covering analysts. Consensus is heavily tilted toward the sidelines: 15 Buy-equivalent ratings (55.6%) vs 18 Hold (66.7%) and 3 Sell (11.1%) from 27 analysts. The mean price target of $29.15 offers 19.9% upside, with a high of $36 and low of $24. HSBC's new $28 target sits exactly at the median, below the mean. The downgrade is contrarian to the 30-day trend of 1 upgrade and 1 downgrade, and EPS revisions have been roughly balanced (11 up vs 8 down for the current fiscal year). Insider activity is minimal — one small sell by an officer in June — and short interest is elevated at 56.3% of off-exchange volume, signaling bearish positioning. The call is a notable bearish signal from a mid-tier firm, but the consensus remains cautiously optimistic.
Impact Score
Consensus & Targets
Of 27 analysts covering PFE, 6 rate it Strong Buy, 9 Buy, 18 Hold, 2 Sell, and 1 Strong Sell. That translates to 55.6% Buy-equivalent, 66.7% Hold, and 11.1% Sell. The consensus is heavily weighted toward neutral-to-positive, making HSBC's downgrade a contrarian move.
Current price: $24.32. Mean target: $29.15 (19.9% upside). Median: $28 (15.1% upside). High: $36 (48.0% upside). Low: $24 (1.3% downside). HSBC's new $28 target is exactly at the median, below the mean, aligning with the more cautious end of the consensus range.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-06 | HSBC | downgrade | Hold | $28.00 |
| 2026-06-10 | RBC Capital | upgrade | Sector Perform | $25.00 |
| 2026-04-29 | Citigroup | maintain | Neutral | $27.00 |
| 2026-04-20 | RBC Capital | reiterate | Underperform | $25.00 |
| 2026-04-16 | CICC | initiate | Outperform | $33.00 |
| 2026-04-13 | UBS | maintain | Neutral | $27.00 |
| 2026-04-10 | Morgan Stanley | maintain | Equal-Weight | $28.00 |
| 2026-04-09 | B of A Securities | maintain | Neutral | $26.00 |
| 2026-03-24 | Guggenheim | maintain | Buy | — |
| 2026-03-17 | HSBC | maintain | Buy | — |
Over the past 30 days, PFE has seen 1 upgrade (RBC Capital from Underperform to Sector Perform on June 10) and 1 downgrade (this HSBC action). EPS revisions for the current fiscal year show 11 upward revisions vs 8 downward in the last 30 days, with the average estimate essentially flat at $2.96. The revision trend is slightly positive but not decisive.
Firm Track Record — HSBC
HSBC accuracy: 55% on 263 calls | avg return: 5.5%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 7 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Morgan Stanley | 71% | 5/7 | 4.2% | top tier |
| B of A Securities | 67% | 2/3 | -0.1% | top tier |
| Cantor Fitzgerald | 59% | 10/17 | 1.8% | above average |
| Citigroup | 50% | 1/2 | -5% | below average |
| Barclays | 50% | 1/2 | -1.2% | below average |
| Guggenheim | 40% | 2/5 | -1.4% | below average |
| UBS | 40% | 2/5 | -2.7% | below average |
HSBC has a 55% accuracy rate on 263 scored calls with an average return of 5.5%. This places it in the middle of the pack — below top-tier firms like Morgan Stanley (71% on 7 calls) and B of A Securities (67% on 3 calls), but above below-average firms like Guggenheim (40% on 5 calls) and UBS (40% on 5 calls).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $0.85 | $0.65 — $0.96 | $16.1B | ↑1 ↓0 |
| 0q | $0.68 | $0.61 — $0.76 | $14.4B | ↑1 ↓0 |
| +1y | $2.83 | $2.43 — $3.10 | $59.3B | ↑1 ↓0 |
| 0y | $2.96 | $2.80 — $3.12 | $61.7B | ↑1 ↓0 |
Cross-Platform Signals
Insider activity: one small sell by officer Jennifer B. Damico on June 9 ($51,400) — non-informative per academic literature. Congressional activity: one small buy by Rep. Ro Khanna on April 13 ($1,001-$15,000) — a minor bullish signal. Institutional changes: several large funds added positions (Walleye Capital doubled its stake, OP Asset Management added 59.2%), while Focus Partners trimmed 38.4%. Short interest is elevated at 56.3% of off-exchange volume, indicating bearish positioning that diverges from the analyst consensus. The insider and congressional signals are weak and do not materially alter the bearish analyst signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Court Ruling | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.59 (+2.95%) |
Aug 12, 2026 7w ago | Insider Buy | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.59 (+2.95%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.59 (+2.95%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.59 (+5.31%) |
Aug 5, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.59 (+5.31%) |
Aug 4, 2026 8w ago | 8-K | $25.41 $28.55 | ▲ +12.36% | ▲ +13.60% | $27.59 (+8.58%) |
Jul 31, 2026 9w ago | Court Ruling | $25.01 $27.96 | ▼ −11.80% | ▼ −8.81% | $27.59 (−10.32%) |
Jul 24, 2026 10w ago | Court Ruling | $24.54 $28.07 | ▲ +14.38% | ▲ +10.76% | $27.59 (+12.43%) |
Jul 6, 2026 12w ago | ANALYST-DOWNGRADE | $23.72 $25.01 | ▼ −5.44% | ▼ −6.00% | $27.59 (−16.32%) |
Jun 18, 2026 15w ago | 8-K | $25.21 $25.14 | ▼ −0.28% | ▼ −0.81% | $27.59 (+9.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access